BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Schioppa T, Sozio F, Barbazza I, Scutera S, Bosisio D, Sozzani S, Del Prete A. Molecular Basis for CCRL2 Regulation of Leukocyte Migration. Front Cell Dev Biol 2020;8:615031. [PMID: 33363177 DOI: 10.3389/fcell.2020.615031] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Liu X, Wang H, Li M, Zhang J, Gao Z, Wan M, Zhang Z, Cai Y, Luan Q, Wang X. Transcriptomic Analysis Identifies Diagnostic Genes in Polycystic Ovary Syndrome and Periodontitis.. [DOI: 10.21203/rs.3.rs-2293696/v1] [Reference Citation Analysis]
2 Macvanin MT, Rizzo M, Radovanovic J, Sonmez A, Paneni F, Isenovic ER. Role of Chemerin in Cardiovascular Diseases. Biomedicines 2022;10:2970. [DOI: 10.3390/biomedicines10112970] [Reference Citation Analysis]
3 Wilson A, Garmo LC, Podgorski I. Interplay between fat cells and immune cells in bone: Impact on malignant progression and therapeutic response. Pharmacology & Therapeutics 2022;238:108274. [DOI: 10.1016/j.pharmthera.2022.108274] [Reference Citation Analysis]
4 Bu H, Jiao P, Fan X, Gao Y, Zhang L, Guo H. The role of botulinum toxin type A related axon transport in neuropathic pain induced by chronic constriction injury. Korean J Pain 2022;35:391-402. [PMID: 36175338 DOI: 10.3344/kjp.2022.35.4.391] [Reference Citation Analysis]
5 Torphy RJ, Yee EJ, Schulick RD, Zhu Y. Atypical chemokine receptors: emerging therapeutic targets in cancer. Trends in Pharmacological Sciences 2022. [DOI: 10.1016/j.tips.2022.09.009] [Reference Citation Analysis]
6 Bufano M, Laffranchi M, Sozzani S, Raimondo D, Silvestri R, Coluccia A. Exploring CCRL2 chemerin binding using accelerated molecular dynamics. Proteins 2022;90:1714-1720. [DOI: 10.1002/prot.26348] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Wilder CL, Lefaudeux D, Mathenge R, Kishimoto K, Munoz AZ, Nguyen MA, Meyer AS, Cheng QJ, Hoffmann A. A stimulus-contingent positive feedback loop enables IFN-β dose-dependent activation of pro-inflammatory genes.. [DOI: 10.1101/2022.08.11.503561] [Reference Citation Analysis]
8 Wu Z, Lin W, Yuan Q, Lyu M. A genome-wide association analysis: m6A-SNP related to the onset of oral ulcers. Front Immunol 2022;13:931408. [DOI: 10.3389/fimmu.2022.931408] [Reference Citation Analysis]
9 Hong JH, Lee YC. Anti-Inflammatory Effects of Cicadidae Periostracum Extract and Oleic Acid through Inhibiting Inflammatory Chemokines Using PCR Arrays in LPS-Induced Lung inflammation In Vitro. Life (Basel) 2022;12:857. [PMID: 35743888 DOI: 10.3390/life12060857] [Reference Citation Analysis]
10 Wu J, Shen S, Liu T, Ren X, Zhu C, Liang Q, Cui X, Chen L, Cheng P, Cheng W, Wu A. Chemerin enhances mesenchymal features of glioblastoma by establishing autocrine and paracrine networks in a CMKLR1-dependent manner. Oncogene 2022. [PMID: 35459783 DOI: 10.1038/s41388-022-02295-w] [Reference Citation Analysis]
11 Stikker BS, Stik G, van Ouwerkerk AF, Trap L, Spicuglia S, Hendriks RW, Stadhouders R. Severe COVID-19-associated variants linked to chemokine receptor gene control in monocytes and macrophages. Genome Biol 2022;23. [DOI: 10.1186/s13059-022-02669-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
12 Karantanos T, Teodorescu P, Perkins B, Christodoulou I, Esteb C, Varadhan R, Helmenstine E, Rajkhowa T, Paun BC, Bonifant C, Dalton WB, Gondek LP, Moliterno AR, Levis MJ, Ghiaur G, Jones RJ. The role of the atypical chemokine receptor CCRL2 in myelodysplastic syndrome and secondary acute myeloid leukemia. Sci Adv 2022;8:eabl8952. [PMID: 35179961 DOI: 10.1126/sciadv.abl8952] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Schlecht-Louf G, Deback C, Bachelerie F. The Chemokine System in Oncogenic Pathways Driven by Viruses: Perspectives for Cancer Immunotherapy. Cancers (Basel) 2022;14:848. [PMID: 35159113 DOI: 10.3390/cancers14030848] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Fischer TF, Beck-Sickinger AG. Chemerin - exploring a versatile adipokine. Biol Chem 2022. [PMID: 35040613 DOI: 10.1515/hsz-2021-0409] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
15 Ben Dhaou C, Del Prete A, Sozzani S, Parmentier M. CCRL2 Modulates Physiological and Pathological Angiogenesis During Retinal Development. Front Cell Dev Biol 2021;9:808455. [PMID: 35004698 DOI: 10.3389/fcell.2021.808455] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Baechle JJ, Hanna DN, Sekhar KR, Rathmell JC, Rathmell WK, Baregamian N. Integrative computational immunogenomic profiling of cortisol-secreting adrenocortical carcinoma. J Cell Mol Med 2021;25:10061-72. [PMID: 34664400 DOI: 10.1111/jcmm.16936] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
17 Al Delbany D, Robert V, Dubois-Vedrenne I, Del Prete A, Vernimmen M, Radi A, Lefort A, Libert F, Wittamer V, Sozzani S, Parmentier M. Expression of CCRL2 Inhibits Tumor Growth by Concentrating Chemerin and Inhibiting Neoangiogenesis. Cancers (Basel) 2021;13:5000. [PMID: 34638484 DOI: 10.3390/cancers13195000] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
18 Karantanos T, Teodorescu P, Perkins B, Christodoulou I, Esteb C, Varadhan R, Helmenstine E, Rajkhowa T, Paun BC, Bonifant C, Dalton WB, Gondek LP, Moliterno AR, Levis MJ, Ghiaur G, Jones RJ. The role of the atypical chemokine receptor CCRL2 in myelodysplastic syndrome and secondary acute myeloid leukemia.. [DOI: 10.1101/2021.07.29.454394] [Reference Citation Analysis]
19 Stikker B, Stik G, Hendriks RW, Stadhouders R. Severe COVID-19 associated variants linked to chemokine receptor gene control in monocytes and macrophages. bioRxiv 2021:2021. [PMID: 33501435 DOI: 10.1101/2021.01.22.427813] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
20 Ishizuka M, Harada M, Nomura S, Ko T, Ikeda Y, Guo J, Bujo S, Yanagisawa-Murakami H, Satoh M, Yamada S, Kumagai H, Motozawa Y, Hara H, Fujiwara T, Sato T, Takeda N, Takeda N, Otsu K, Morita H, Toko H, Komuro I. CXCR7 ameliorates myocardial infarction as a β-arrestin-biased receptor. Sci Rep 2021;11:3426. [PMID: 33564089 DOI: 10.1038/s41598-021-83022-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
21 Baechle JJ, Hanna DN, Konjeti SR, Rathmell JC, Rathmell WK, Baregamian N. Multiplatform Integrative Analyses of Immunosuppressive Signatures in Cortisol-secreting Adrenocortical Carcinoma.. [DOI: 10.1101/2021.01.14.426712] [Reference Citation Analysis]